Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events
- 1 September 2002
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 62 (3) , 949-955
- https://doi.org/10.1046/j.1523-1755.2002.00504.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patientsKidney International, 2001
- Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failureKidney International, 1999
- ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphismsTransplant Immunology, 1999
- Expression of Interleukin-10 in Advanced Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Leukocyte-Suppressing Influences of Interleukin (IL)-10 in Cardiac Allografts: Insights from IL-10 Knockout MiceThe American Journal of Pathology, 1998
- Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical reportTransplant Immunology, 1998
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Production of interleukin-6, tumor necrosis factor α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patientsKidney International, 1995
- Interleukin-10Annual Review of Immunology, 1993